Company / Operating Income per Share
Aquestive Therapeutics, Inc. Operating Income per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$0.78
FY2025
5-year range
-$1.24 / -$0.28
FY2021-FY2025
Trend
-73.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $-0.28 to $-0.78 over the past 2 years.
Based on SEC 10-K filings.
-0.78 in FY2025.
Declined from $-0.28 to $-0.78 over the past 2 years.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating income per share decreased 73.1% year-over-year.
- Peak operating income per share was recorded in FY2018.
- Lowest operating income per share in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -3.08 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.78 | -73.1% |
| FY2024 | -$0.45 | -63.0% |
| FY2023 | -$0.28 | +73.0% |
| FY2022 | -$1.02 | +17.8% |
| FY2021 | -$1.24 | +20.9% |
| FY2020 | -$1.57 | +20.0% |
| FY2019 | -$1.96 | -43204.4% |
| FY2018 | -$0.00 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026